
Dobri Kiprov, MD
Chief Medical Officer
Dr. Dobri Kiprov is a leading expert in Therapeutic Apheresis with over 30 years of experience. He has served two terms on the American Society for Apheresis (ASFA) Board, has earned multiple honors, and has published more than 100 publications. Kiprov’s most recent research has established him as a leader in the prevention and treatment of age-related medical conditions, as well as holding patents for the composition and methods of TPE.